Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.433 USD | +6.65% | -0.68% | -16.65% |
Apr. 30 | Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product | CI |
Apr. 30 | Akili, Inc. to Reduce Workforce | CI |